Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2014 · 10-Q
Revenue$233.00$233.00−33.8% vs Q3 2013 Net Income-$6.64M-$6.64MN/M vs Q3 2013 EPS Diluted-$0.11-$0.11— vs Q3 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,721N/M Margins · derivedGross margin-930.0%−177.8 pt vs Q3 2013
Operating margin-41258.8%−13999.1 pt vs Q3 2013
Net margin-2849039.9%−2824755.8 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end